Pediatric ID News

WASHINGTON — Neonates with sepsis were exposed to more antibiotics throughout their NICU admissions than controls and were found to have microbiome dysbiosis, researchers reported.

WASHINGTON — A MRSA PCR nasal swab showed promise as a tool for antimicrobial stewardship in a large study of pediatric critical care patients, according to findings presented here at IDWeek.

WASHINGTON — Some infants with in utero or early life exposure to SARS-CoV-2 had borderline to low developmental scores, a study found, and this was most common among babies born to mothers with symptomatic COVID-19.

WASHINGTON — Pediatric influenza vaccination rates remain suboptimal compared with other childhood vaccines, and parents are even less concerned about influenza since the start of the COVID-19 pandemic, according to data reported here.

The FDA has granted an emergency use authorization for booster doses of Moderna and Pfizer-BioNTech’s omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines for children and adolescents, both companies announced today.

ANAHEIM, Calif. — A study found that having a pre-existing comorbidity was the strongest indicator of risk for severe COVID-19 in children, according to data reported here.

ANAHEIM, Calif. — Anne Schuchat, MD, former principal deputy director of the CDC, has a message for pediatricians.

In the United States, COVID-19 vaccinations may have prevented more than 650,000 hospitalizations and 300,000 deaths among Medicare beneficiaries in 2021, according to a new report from HHS.

New research has linked the incidence of unexplained hepatitis in pediatric patients to a pair of viruses — adenovirus type F41 and adeno-associated virus 2 — as well as potential markers of genetic mutation.

Pregnant patients with COVID-19 who were hospitalized for symptomatic disease were more likely to deliver during their stay if they were admitted to the hospital during non-omicron pandemic waves, data showed.